Cargando…

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration

A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Idogun, Precious O, Ward, Mindy C, Teklie, Yeshanew, Wiese-Rometsch, Wilhelmine, Baker, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/
https://www.ncbi.nlm.nih.gov/pubmed/34113494
http://dx.doi.org/10.7759/cureus.14853
_version_ 1783703289795182592
author Idogun, Precious O
Ward, Mindy C
Teklie, Yeshanew
Wiese-Rometsch, Wilhelmine
Baker, Joel
author_facet Idogun, Precious O
Ward, Mindy C
Teklie, Yeshanew
Wiese-Rometsch, Wilhelmine
Baker, Joel
author_sort Idogun, Precious O
collection PubMed
description A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease.
format Online
Article
Text
id pubmed-8176657
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-81766572021-06-09 Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration Idogun, Precious O Ward, Mindy C Teklie, Yeshanew Wiese-Rometsch, Wilhelmine Baker, Joel Cureus Internal Medicine A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease. Cureus 2021-05-05 /pmc/articles/PMC8176657/ /pubmed/34113494 http://dx.doi.org/10.7759/cureus.14853 Text en Copyright © 2021, Idogun et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Idogun, Precious O
Ward, Mindy C
Teklie, Yeshanew
Wiese-Rometsch, Wilhelmine
Baker, Joel
Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
title Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
title_full Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
title_fullStr Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
title_full_unstemmed Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
title_short Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
title_sort newly diagnosed idiopathic thrombocytopenia post covid-19 vaccine administration
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/
https://www.ncbi.nlm.nih.gov/pubmed/34113494
http://dx.doi.org/10.7759/cureus.14853
work_keys_str_mv AT idogunpreciouso newlydiagnosedidiopathicthrombocytopeniapostcovid19vaccineadministration
AT wardmindyc newlydiagnosedidiopathicthrombocytopeniapostcovid19vaccineadministration
AT teklieyeshanew newlydiagnosedidiopathicthrombocytopeniapostcovid19vaccineadministration
AT wieserometschwilhelmine newlydiagnosedidiopathicthrombocytopeniapostcovid19vaccineadministration
AT bakerjoel newlydiagnosedidiopathicthrombocytopeniapostcovid19vaccineadministration